<DOC>
	<DOCNO>NCT02526368</DOCNO>
	<brief_summary>This pilot study evaluate pre-surgical patient histologically confirm localized prostate cancer receive infusion hyperpolarized pyruvate ( 13C ) injection undergo metabolic MR image endorectal coil within 12 week subsequent radical prostatectomy .</brief_summary>
	<brief_title>A Pilot Study ( MR ) Imaging With Pyruvate ( 13C ) Detect High Grade Prostate Cancer</brief_title>
	<detailed_description>This pilot study evaluate pre-surgical patient histologically confirm localized prostate cancer receive infusion hyperpolarized pyruvate ( 13C ) injection undergo metabolic MR image endorectal coil within 12 week subsequent radical prostatectomy . At least 20 patient require high risk disease define primary Gleason score 4 5 prior prostate biopsy .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Biopsyproven adenocarcinoma prostate . Biopsy may perform outside UCSF , detailed result sextant biopsy available . A minimum 20 patient plan enrollment 50 patient must highrisk disease define primary Gleason score 4 5 prior prostate biopsy . Planned radical prostatectomy UCSF within 12 week follow protocol MRI/MRSI . The subject able willing comply study procedure provide sign date informed consent . Eastern Cooperative Oncology Group ( ECOG ) Performance Status 0 1 . Adequate organ function , include absolute neutrophil count ( ANC ) ≥1500 cells/μL , hemoglobin ≥9.0 gm/dL , platelet ≥75,000 cells/μL , estimate creatinine clearance ≥50 mL/min ( Cockcroft Gault equation ) , bilirubin &lt; 1.5x ULN ( unless Gilbert 's suspect ) , aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) &lt; 1.5x ULN . For patient partner childbearing potential , willing use adequate contraception one month undergo HP pyruvate infusion . Patients age less 18 year old , general medical psychiatric condition , physiologic status give valid inform consent . Patients unwilling unable undergo MR imaging , include patient contraindication MRI , cardiac pacemaker noncompatible intracranial vascular clip . Patients tolerate contraindication endorectal coil insertion ; example , patient prior abdominoperineal resection rectum latex allergy . Patients contraindication injection gadolinium contrast ; example patient prior document allergy inadequate renal function . Metallic hip implant metallic implant device distorts local magnetic field compromise quality MR imaging . Cryosurgery , surgery prostate cancer , prostatic pelvic radiotherapy prior study enrollment . No limit number prior prostate biopsy . Prior TURP allow . Current prior androgen deprivation therapy . A history use 5α reductase inhibitor allow , provide discontinue least one month prior study entry . Poorly control hypertension , blood pressure study entry &gt; 160/100 . The addition antihypertensives control blood pressure allow eligibility determination . Congestive heart failure New York Heart Association ( NYHA ) status ≥ 2 . A history clinically significant EKG abnormality , include QT prolongation , family history prolong QT interval syndrome , myocardial infarction ( MI ) within 6 month study entry . Patients ratecontrolled atrial fibrillation/flutter allow study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>